Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 6/18/25 → 6/18/27 |
Funding
- Vertex Pharmaceuticals Inc: $32,891.00
A Phase 1 Study of VX-828 in Healthy Subjects and in Subjects with Cystic Fibrosis (VX23-828-001)
- Wurth, Mark (PI)
- Anstead, Michael (CoI)
- Cosentino Roa, Maria (CoI)
- Ramdial, Faizal (CoI)